HER2 testing in the UK: recommendations for breast and gastric in-situ hybridisation methods

Bartlett, J. M. S., Starczynski, J., Atkey, N., Kay, E., O'Grady, A., Gandy, M., Ibrahim, M., Jasani, Bharat, Ellis, I. O., Pinder, S. E. and Walker, R. A. 2011. HER2 testing in the UK: recommendations for breast and gastric in-situ hybridisation methods. Journal of Clinical Pathology 64 (8) , pp. 649-653. 10.1136/jcp.2011.089847

Full text not available from this repository.

Abstract

These guidelines supplement existing guidelines on HER2 testing by immunohistochemistry and in-situ hybridisation(ISH) methods in the UK. They provide a specific focus on aspects of guidance relevant to HER2 ISH testing methods, both fluorescent and chromogenic. They are formulated to give advice on methodology, interpretation and quality control for ISH-based testing of HER2 status in common tumour types, including both breast and gastric tumours. The aim is to ensure that all ISH-based testing is accurate, reliable and timely.

Item Type:	Article
Date Type:	Publication
Status:	Published
Schools:	Medicine
Subjects:	R Medicine > R Medicine (General)
Publisher:	BMJ Publishing Group
ISSN:	0021-9746
Last Modified:	18 Mar 2023 02:06
URI:	https://orca.cardiff.ac.uk/id/eprint/28301

Citation Data

Cited 62 times in Scopus. View in Scopus. Powered By Scopus® Data

Actions (repository staff only)

Edit Item